A. Van-tubergen and U. Weber, Diagnosis and classification in spondyloarthritis: identifying a chameleon, Nature Reviews Rheumatology. mai, vol.8, issue.5, pp.253-61, 2012.

P. Claudepierre, D. Wendling, M. Breban, P. Goupillle, and M. Dougados, Ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, or spondylarthritis: What's in a name?, Joint Bone Spine. déc, vol.79, issue.6, pp.534-539, 2012.

. Wendling, 2013 -Pourquoi un diagnostic et une prise en charge préc

, Poddubnyy et Rudwaleit -2012 -Early Spondyloarthritis.pdf

D. Wendling, C. Lukas, C. Prati, P. Claudepierre, L. Gossec et al., Actualisation 2018 des recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite, Revue du Rhumatisme. mai, vol.85, issue.3, pp.222-252, 2018.

P. Carron, G. Varkas, H. Cypers, L. Van-praet, D. Elewaut et al., Anti-TNFinduced remission in very early peripheral spondyloarthritis: the CRESPA study, Annals of the Rheumatic Diseases. août, vol.76, issue.8, pp.1389-95, 2017.

S. Linden, H. A. Valkenburg, and A. Cats, Evaluation of Diagnostic Criteria for Ankylosing Spondylitis, Arthritis & Rheumatism. avr, vol.27, issue.4, pp.361-369, 1984.

J. Sieper, M. Rudwaleit, X. Baraliakos, J. Brandt, J. Braun et al., The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis, Annals of the Rheumatic Diseases. 1 juin, vol.68, issue.2, pp.1-44, 2009.

A. Van-tubergen and U. Weber, Diagnosis and classification in spondyloarthritis: identifying a chameleon, Nature Reviews Rheumatology. mai, vol.8, issue.5, pp.253-61, 2012.

D. Van-der-heijde, J. Sieper, W. P. Maksymowych, M. Dougados, R. Burgos-vargas et al., Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis, Annals of the Rheumatic Diseases. 1 juin, vol.70, issue.6, pp.905-913, 2010.

N. Haroon, R. D. Inman, T. J. Learch, M. H. Weisman, M. Lee et al., The Impact of TNF-inhibitors on radiographic progression in Ankylosing Spondylitis, Arthritis & Rheumatism. juin, 2013.

S. Linden, H. A. Valkenburg, and A. Cats, Evaluation of Diagnostic Criteria for Ankylosing Spondylitis, Arthritis & Rheumatism. avr, vol.27, issue.4, pp.361-369, 1984.

J. Sieper, M. Rudwaleit, X. Baraliakos, J. Brandt, J. Braun et al., The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis, Annals of the Rheumatic Diseases. 1 juin, vol.68, issue.2, pp.1-44, 2009.

P. Mandl, V. Navarro-compán, L. Terslev, P. Aegerter, D. Van-der-heijde et al., EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice, Annals of the Rheumatic Diseases. juill, vol.74, issue.7, pp.1327-1366, 2015.

K. Hermann, X. Baraliakos, D. M. Van-der-heijde, A. Jurik, R. Landewé et al., Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group, Annals of the Rheumatic Diseases. août, vol.71, issue.8, pp.1278-88, 2012.

A. N. Bennett, A. Rehman, E. Hensor, H. Marzo-ortega, P. Emery et al., Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondylarthritis, Arthritis & Rheumatism. mai, vol.60, issue.5, pp.1331-1372, 2009.

M. Rudwaleit, D. Van-der-heijde, R. Landewe, J. Listing, N. Akkoc et al., The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection, Annals of the Rheumatic Diseases. 1 juin, vol.68, issue.6, pp.777-83, 2009.

A. Van-tubergen, The changing clinical picture and epidemiology of spondyloarthritis, Nature Reviews Rheumatology. févr, vol.11, issue.2, pp.110-118, 2015.

R. Van-den-berg, M. De-hooge, F. Van-gaalen, M. Reijnierse, T. Huizinga et al., Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort, Rheumatology. 1 août, vol.52, issue.8, pp.1492-1501, 2013.

R. Van-den-berg, G. Lenczner, F. Thévenin, P. Claudepierre, A. Feydy et al., Classification of axial SpA based on positive imaging (radiographs and/or MRI of the
URL : https://hal.archives-ouvertes.fr/hal-01030844

L. Heuft-dorenbosch, R. Weijers, and R. Landewé, Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities, Arthritis Research, vol.8, issue.1, p.6

A. Larbi, P. Viala, N. Molinari, C. Lukas, M. P. Baron et al., Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis: Spinal Inflammation on MRI Without SI Joint Inflammation in Nonradiographic Axial SpA, Arthritis & Rheumatology. mars, vol.43, issue.3, pp.667-73, 2014.

A. Larbi, B. Fourneret, C. Lukas, M. Baron, N. Molinari et al., Prevalence and topographic distribution of spinal inflammation on MR imaging in patients recently diagnosed with axial spondyloarthritis. Diagnostic and Interventional Imaging, vol.98, pp.347-53, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01798435

M. Rudwaleit, S. Schwarzlose, E. S. Hilgert, J. Listing, J. Braun et al., MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Annals of the Rheumatic Diseases, vol.67, pp.1276-81, 2007.

R. Lambert, P. Bakker, D. Van-der-heijde, U. Weber, M. Rudwaleit et al., Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Annals of the Rheumatic Diseases, vol.75, pp.1958-63, 2016.

U. Weber, V. Zubler, Z. Zhao, R. G. Lambert, S. M. Chan et al., Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with nonradiographic axial spondyloarthritis? Annals of the Rheumatic Diseases, juin, vol.74, issue.6, pp.985-92, 2015.

S. Z. Aydin, W. P. Maksymowych, A. N. Bennett, D. Mcgonagle, P. Emery et al., Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years, Annals of the Rheumatic Diseases. janv, vol.71, issue.1, pp.56-60, 2012.

M. De-hooge, R. Van-den-berg, V. Navarro-compán, M. Reijnierse, F. Van-gaalen et al., Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?, Annals of the Rheumatic Diseases. juill, vol.75, issue.7, pp.1308-1322, 2016.

U. Weber, R. Lambert, M. Østergaard, J. Hodler, S. J. Pedersen et al., The diagnostic utility of magnetic resonance imaging in spondylarthritis: An international multicenter evaluation of one hundred eighty-seven subjects, Arthritis & Rheumatism. 23 mai, vol.62, issue.10, pp.3048-58, 2010.

U. Weber, V. Zubler, S. J. Pedersen, K. Rufibach, R. Lambert et al., Development and Validation of a Magnetic Resonance Imaging Reference Criterion for Defining a Positive Sacroiliac Joint Magnetic Resonance Imaging Finding in Spondyloarthritis: MRI Reference Criterion for SpA in SI Joints, Arthritis Care & Research. juin, vol.65, issue.6, pp.977-85, 2013.

T. H. Darrah, J. J. Prutsman-pfeiffer, R. J. Poreda, E. Campbell, M. Hauschka et al., Incorporation of excess gadolinium into human bone from medical contrast agents, Metallomics, vol.1, issue.6, p.479, 2009.

T. Kanda, T. Fukusato, M. Matsuda, K. Toyoda, H. Oba et al., Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy, Radiology. juill, vol.276, issue.1, pp.228-260, 2015.

R. Pullicino, M. Radon, S. Biswas, M. Bhojak, and K. Das, A Review of the Current Evidence on Gadolinium Deposition in the Brain, Clinical Neuroradiology. juin, vol.28, issue.2, pp.159-69, 2018.

U. Kiltz, X. Baraliakos, P. Karakostas, M. Igelmann, L. Kalthoff et al., Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?, Arthritis Care & Research. sept, vol.64, issue.9, pp.1415-1437, 2012.

A. Moltó, S. Paternotte, D. Van-der-heijde, P. Claudepierre, M. Rudwaleit et al., Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort, Annals of the Rheumatic Diseases. avr, vol.74, issue.4, pp.746-51, 2015.

M. Rudwaleit, H. Haibel, X. Baraliakos, J. Listing, E. Märker-hermann et al., The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort, Arthritis & Rheumatism. mars, vol.60, issue.3, pp.717-744, 2009.

A. Kavanaugh, L. Puig, A. B. Gottlieb, C. Ritchlin, Y. You et al., Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebocontrolled studies (PSUMMIT-1/PSUMMIT-2). Annals of the Rheumatic Diseases, vol.75, pp.1984-1992, 2016.

P. J. Mease, I. B. Mcinnes, B. Kirkham, A. Kavanaugh, P. Rahman et al., Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis, New England Journal of Medicine, vol.373, issue.14, pp.1329-1368, 2013.

, Note -Percentages were rounded. Numbers in brackets are limits of confidence intervals 95%

, PPV = Positive predictive value NPV = Negative predictive value AUC = Area under the curve Au moment d'être admise à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Admise dans l'intimité des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés. J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité. Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

. __________________________________________________________________________________________-place, IRM dans le diagnostic des spondyloarthrites et évaluation de l'intérêt de l'injection de gadolinium : étude prospective monocentrique sur une période de 5 ans